November 13, 2017 / 1:20 PM / a month ago

BRIEF-Interpace Diagnostics says Q3 sales up 27 pct

Nov 13 (Reuters) - Interpace Diagnostics Group Inc:

* Interpace diagnostics group reports third quarter 2017 financial results, business progress and recent accomplishments

* Q3 sales rose 27 percent to $4.2 million

* Interpace diagnostics group inc qtrly ‍net loss per diluted share of common stock $0.15​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below